Aurobindo Pharma Limited — Updates, 03-06-2026: Press Release
03-06-2026 | 05:43 pm
03-06-2026 | 05:43 pm
Aurobindo Pharma inaugurated TheraNym, India's large-scale biologics CMO facility, with MSD as its anchor customer. This strategically expands Aurobindo into the high-growth biologics contract manufacturing market, enhancing its global presence.
No comments yet. Be the first to comment!
